 |
evolocumab |
|---|---|
| Trade Name | Repatha |
| Orphan Indication | Homozygous Familial Hypercholesterolemia |
| USA Market Approval | USA |
| USA Designation Date | 2013-09-12 00:00:00 |
| Sponsor | Amgen Inc.;One Amgen Center Drive, M/S 17 2 B;Thousand Oaks, California, 91320 |
| |
evolocumab |
|---|---|
| Trade Name | Repatha |
| Orphan Indication | Homozygous Familial Hypercholesterolemia |
| USA Market Approval | USA |
| USA Designation Date | 2013-09-12 00:00:00 |
| Sponsor | Amgen Inc.;One Amgen Center Drive, M/S 17 2 B;Thousand Oaks, California, 91320 |